Clinical Experience of Small-cell Carcinomas of the Stomach.
10.5230/jkgca.2005.5.4.252
- Author:
Hyoung Ju KIM
1
;
Sung Joon KWON
;
Moon Hyang PARK
Author Information
1. Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Small-cell carcinoma of the stomach;
Treatment;
Prognosis
- MeSH:
Adenocarcinoma;
Cisplatin;
Disease Progression;
Drug Therapy;
Etoposide;
Follow-Up Studies;
Gastrectomy;
Hepatomegaly;
Humans;
Ifosfamide;
Liver;
Lymph Node Excision;
Lymph Nodes;
Lymphatic Diseases;
Male;
Mastectomy, Segmental;
Mesna;
Neoplasm Metastasis;
Prognosis;
Stomach*;
Tomography, X-Ray Computed
- From:Journal of the Korean Gastric Cancer Association
2005;5(4):252-259
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To clarify the clinicopathologic features of small-cell carcinomas (SCC) of the stomach, we reviewed three cases of surgically treated SCC. The first case was a pure SCC, with severe pancreatic invasion and peritoneal seeding. A gastro-jejunostomy was performed. Postoperative chemotherapy was performed with CDDP and VP-16 (8 cycles), but showed disease progression (PD); a consecutive chemotherapy with CDDP and irinotencan (2 cycles) also showed PD. A third line with CDDP, VP16, ifosfamide, and mesna was followed by a 4th line (CDDP and Taxol). The male patient died with liver metastasis and peritoneal seeding 14 months after the operation. The second case was a SCC mixed with a poorly differentiated adenocarcinoma. Profound lymphadenopathy and liver metastasis were found. Two cycles of preoperative chemotherapy with TS-1 and CDDP were performed, which showed nearly complete remission for lymphadenopathy and partial response for the primary tumor site and liver metastatic lesion. A total gastrectomy and extended lymphadenectomy was performed. There were no viable cancer cells in 35 retrieved lymph nodes. Postoperative chemotherapy using the same regimen was performed for 4 cycles. Enlarged liver metastasis was found at the follow-up CT scan, so a posterior segmentectomy of liver was performed. After liver surgery, the chemotherapy regimen was changed to irinotecan and cisplatin. This male patient has been in good health for the 14 months since gastric surgery. The third case was a pure SCC, and a subtotal gastrectomy was performed curatively. That male patient received 5 cycles of TS-1 and is still in good health 14 months after operation.
